201 related articles for article (PubMed ID: 17116220)
1. Expression of chemokine receptors on peripheral blood mononuclear cells of patients with immune-mediated neuropathies treated with intravenous immunoglobulins.
Trebst C; Brunhorn K; Lindner M; Windhagen A; Stangel M
Eur J Neurol; 2006 Dec; 13(12):1359-63. PubMed ID: 17116220
[TBL] [Abstract][Full Text] [Related]
2. Altered chemokine receptor profile on circulating leukocytes in human heart failure.
Athanassopoulos P; Vaessen LM; Balk AH; Weimar W; Sharma HS; Bogers AJ
Cell Biochem Biophys; 2006; 44(1):83-101. PubMed ID: 16456237
[TBL] [Abstract][Full Text] [Related]
3. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
4. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
Lehmann HC; Hartung HP
J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913
[TBL] [Abstract][Full Text] [Related]
5. High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.
McAlpine SM; Roberts SE; Heath JJ; Käsermann F; Issekutz AC; Issekutz TB; Derfalvi B
Front Immunol; 2021; 12():660506. PubMed ID: 34093549
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytosis is a common immune signature in patients with MMN and CIDP and responds to treatment with IVIg.
Korporal-Kuhnke M; Haas J; Schwarz A; Jarius S; Wildemann B
J Neuroimmunol; 2015 Jan; 278():60-8. PubMed ID: 25595253
[TBL] [Abstract][Full Text] [Related]
7. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
Katschke KJ; Rottman JB; Ruth JH; Qin S; Wu L; LaRosa G; Ponath P; Park CC; Pope RM; Koch AE
Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
[TBL] [Abstract][Full Text] [Related]
9. Impaired CD4 and CD8 T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children.
Hedman M; Faresjö M; Axelsson S; Ludvigsson J; Casas R
Clin Exp Immunol; 2008 Sep; 153(3):360-8. PubMed ID: 18803760
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis.
Gattorno M; Prigione I; Morandi F; Gregorio A; Chiesa S; Ferlito F; Favre A; Uccelli A; Gambini C; Martini A; Pistoia V
Arthritis Res Ther; 2005; 7(2):R256-67. PubMed ID: 15743472
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
Dyer WB; Tan JC; Day T; Kiers L; Kiernan MC; Yiannikas C; Reddel S; Ng K; Mondy P; Dennington PM; Dean MM; Trist HM; Dos Remedios C; Hogarth PM; Vucic S; Irving DO
Brain Behav; 2016 Oct; 6(10):e00516. PubMed ID: 27781132
[TBL] [Abstract][Full Text] [Related]
12. Selective suppression of chemokine receptor CXCR3 expression by interferon-beta1a in multiple sclerosis.
Sørensen TL; Sellebjerg F
Mult Scler; 2002 Apr; 8(2):104-7. PubMed ID: 11990865
[TBL] [Abstract][Full Text] [Related]
13. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment with intravenous immunoglobulins reduces autoreactive T-cell response in patients with CIDP.
Klehmet J; Goehler J; Ulm L; Kohler S; Meisel C; Meisel A; Harms H
J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):686-91. PubMed ID: 25074566
[TBL] [Abstract][Full Text] [Related]
15. Circulating lymphocyte and T memory subsets in glucocorticosteroid versus IVIG treated patients with CIDP.
Klehmet J; Staudt M; Ulm L; Unterwalder N; Meisel A; Meisel C
J Neuroimmunol; 2015 Jun; 283():17-22. PubMed ID: 26004151
[TBL] [Abstract][Full Text] [Related]
16. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production.
Tawfik DS; Cowan KR; Walsh AM; Hamilton WS; Goldman FD
Pediatr Allergy Immunol; 2012 Feb; 23(1):88-95. PubMed ID: 21265884
[TBL] [Abstract][Full Text] [Related]
17. Recovery of the T-cell repertoire in CIDP by IV immunoglobulins.
Mausberg AK; Dorok M; Stettner M; Müller M; Hartung HP; Dehmel T; Warnke C; Meyer Zu Hörste G; Kieseier BC
Neurology; 2013 Jan; 80(3):296-303. PubMed ID: 23269592
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients.
Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Matsumura Y; Kondo T; Yoshie O; Itoyama Y
J Neuroimmunol; 2006 Mar; 172(1-2):166-74. PubMed ID: 16427705
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
[TBL] [Abstract][Full Text] [Related]
20. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.
Chi LJ; Wang HB; Zhang Y; Wang WZ
J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
